Functional role of inhibitory and excitatory nerves in the porcine lower urinary tract

European Journal of Pharmacology

Volumn 456, Issue 1-3, 2002, Pages 81-90

  Noda, Kumiko ^a   Takebe, Mika ^a   Oka, Michiko ^a   Hirouchi, Masaaki ^a   Ukai, Yojiro ^a   Toda, Noboru ^a  

^a NIPPON SHINYAKU CO LTD   (Japan)

Author keywords

Nitrergic nerve; Nitric oxide (NO); Sphincter; Trigone; Urethra

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; APAMIN; ARGININE; ATROPINE; CAPSAICIN; CHARYBDOTOXIN; CHYMOTRYPSIN; CHYMOTRYPSIN A; CYANOPINDOLOL; CYCLIC GMP; GLIBENCLAMIDE; GUANOSINE TRIPHOSPHATE; GUANYLATE CYCLASE; IBERIOTOXIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PAPAVERINE; POTASSIUM CHANNEL; PRAZOSIN; PROPRANOLOL; PROSTAGLANDIN F2 ALPHA; TETRODOTOXIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE DERIVATIVE; VASOACTIVE INTESTINAL POLYPEPTIDE[DEXTRO 4 CLORO 6 PHENYLALANINE 1 LEUCINE 7]; YOHIMBINE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ENZYME INHIBITOR; NITRIC OXIDE SYNTHASE; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DETRUSOR MUSCLE; DOSE RESPONSE; DRUG EFFECT; ELECTROSTIMULATION; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; SWINE; URETHRA; ANIMAL; BLADDER; COMPARATIVE STUDY; DRUG ANTAGONISM; IN VITRO STUDY; INNERVATION; METABOLISM; URINARY TRACT;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ARGININE; ATROPINE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; ENZYME INHIBITORS; FEMALE; MALE; MUSCLE CONTRACTION; MUSCLE RELAXATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PAPAVERINE; PRAZOSIN; SWINE; TETRODOTOXIN; URETHRA; URINARY BLADDER; URINARY TRACT; VASODILATOR AGENTS; YOHIMBINE;

EID: 0037027916     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02585-2     Document Type: Article

References (35)

1. Andersson K.E. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol. Rev. 45:1993;253-308.
2. Andersson K.E., Alm P. Neurogenic nitric oxide and the lower urinary tract. Toda N., Moncada S., Furchgott R.F., Higgs E.A. Nitric Oxide and Peripheral Nervous System. 2000;77-97 Pergamon, London.
3. Andersson K.E., Pascual A.G., Forman A., Tottrup A. Non-adrenergic, non-cholinergic nerve-mediated relaxation of rabbit urethra is caused by nitric oxide. Acta Physiol. Scand. 141:1991;133-134.
4. Bauersachs J., Popp R., Hecker M., Sauer E., Fleming I., Busse R. Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor. Circ. Res. 94:1996;3341-3347.
5. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Bridgewater M., MacNeil H.F., Brading A.F. Regulation of tone in pig urethral smooth muscle. J. Urol. 150:1993;223-228.
7. Bult H., Boeckxstaaens G.E., Pelckmans P.A., Jordaens F.H., Van Maercke Y.M., Herman A.G. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature. 345:1990;346-347.
8. Burnett A.L., Lowenstein C.J., Bredt D.S., Chang T.S.K., Snyder S.H. Nitric oxide: a physiologic mediator of penile erection. Science. 257:1992;401-403.
9. G-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle. Life Sci. 48:1991;2429-2436.
10. Ehren I., Adolfsson J., Wilkund N.P. Nitric oxide synthase activity in the human urogenital tract. Urol. Res. 22:1994;287-290.
11. Garthwaite J., Southam E., Boulton C.L., Nielsen E.B., Schmidt K., Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylate cyclase by 1H-[1,2,4]oxadiazolo[4,4a]quinoxalin-1-on. Mol. Pharmacol. 48:1995;184-188.
12. G-monomethyl L-arginine on the response of the rat anococcygeus muscle to NANC nerve stimulation. Br. J. Pharmacol. 98:1989;1080-1082.
13. Hashimoto S., Kigoshi S., Muramatsu I. Neurogenic responses of urethra isolated from the dog. Eur. J. Pharmacol. 213:1992;117-123.
14. Hashimoto S., Kigoshi S., Mutamatsu I. Nitric oxide-dependent and -independent neurogenic relaxation of isolated dog urethra. Eur. J. Pharmacol. 231:1993;209-214.
15. Hoey A., Jackson C., Pegg G., Sillence M. Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol. Br. J. Pharmacol. 117:1996;712-716.
16. 3-adrenoceptor in the human detrusor muscle. Br. J. Pharmacol. 126:1999;819-825.
17. Levin R.M., Ruggieri M.R., Wein A.J. Identification of receptor subtypes in the rabbit and human urinary bladder by selective radio-ligand binding. J. Urol. 139:1988;844-888.
18. Li C.G., Rand M.J. Evidence for a role of nitric oxide in the muscle to NANC nerve stimulation. Br. J. Pharmacol. 98:1989;1080-1082.
19. McCulloch A.I., Bottrill F.E., Randall M.D., Hiley C.R. Characterization and modulation of EDRF-mediated relaxations in the rat isolated superior mesenteric arterial bed. Br. J. Pharmacol. 120:1997;1431-1438.
20. 3-adrenoceptors) mediating relaxation in the rat distal colon in vitro. Br. J. Pharmacol. 101:1990;569-574.
21. 1-adrenoceptor antagonist: possible clinical relevance. Eur. J. Pharmacol. 415:2001;209-216.
22. 2+ channel. J. Pharmacol. Exp. Ther. 293:2000;522-529.
23. Oka M., Hirouchi M., Itoh Y., Ukai Y. Involvement of peroxynitrite and hydroxyradical generated from nitric oxide in hypoxia/reoxygenation injury in rat cerebrocortical slices. Neuropharmacology. 39:2000;1319-1330.
24. Okamura T., Ayajiki K., Toda N. Monkey corpus cavernosum relaxation mediated by NO and other relaxing factor derived from nerves. Am. J. Physiol. 274:1998;H1075-H1081.
25. Persson K., Andersson K.E. Nitric oxide and relaxation of pig lower urinary tract. Br. J. Pharmacol. 106:1992;416-422.
26. Persson K., Alm P., Johansson K., Larsson B., Andersson K.E. Nitric oxide synthase in pig lower urinary tract: immunohistochemistry, NADPH diaphorase histochemistry and functional effects. Br. J. Pharmacol. 110:1993;521-530.
27. Sibley G.N. A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit. J. Physiol. 354:1984;431-443.
28. Speakman M.J., Walmsley D., Brading A.F. An in vitro pharmacological study of the human trigone - a site of non-adrenergic, non-cholinergic neurotransmission. Br. J. Urol. 61:1988;304-309.
29. Toda N., Okamura T. Possible role of nitric oxide in transmitting information from vasodilator nerve to cerebroarterial muscle. Biochem. Biophys. Res. Commun. 170:1990;308-313.
30. Toda N., Okamura T. Mechanism underlying the response to vasodilator nerve stimulation in isolated dog and monkey cerebral arteries. Am. J. Physiol. 259:1990;H1511-H1517.
31. Toda N., Baba H., Okamura T. Role of nitric oxide in non-adrenergic, non-cholinergic nerve-mediated relaxation in dog duodenal longitudinal muscle strips. Jpn. J. Pharmacol. 53:1990;281-284.
32. Toda M., Okamura T., Ayajild K., Toda N. Neurogenic vasoconstriction as affected by cholinergic and nitroxidergic nerves in dog ciliary and ophthalmic arteries. Invest. Ophthalmol. Visual Sci. 40:1999;1753-1760.
33. Turner W.H. Evidence against regulation of bladder compliance by nitric oxide. J. Urol. 151:1994;377A. (abstract).
34. Werkstrom V., Persson K., Ny L., Bridgewater M., Brading A.F., Andersson K.E. Factors involved in the relaxation of female pig urethra evoked by electrical field stimulation. Br. J. Pharmacol. 116:1995;1599-1604.
35. 2-adrenoceptors and potassium channels. Br. J. Pharmacol. 121:1997;1605-1612.